Clin2
NCT05152368Possibly a fitRecruiting

Tested umbilical cord stem cell exosomes for trigeminal nerve pain

Peripheral NeuropathyTrigeminal Neuralgia

Treatments studied

Part of Brain & nervous system, Mouth & dental clinical trials.

This Phase 1 study tests whether a treatment made from donated umbilical cord stem cell “exosomes” is safe for people with trigeminal neuralgia (severe facial nerve pain). It mainly focuses on safety and tolerability, and it may help by calming nerve-related pain pathways.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
20 people
Ages
Any age
Study type
Interventional

Who can take part

  • You have been diagnosed with trigeminal neuralgia or a peripheral (outside the brain) nerve problem
  • You are willing to read and sign an informed consent form in writing
  • You do not have a current active infection
  • You do not have active cancer
  • You are not pregnant (or, if you could become pregnant, you use reliable birth control)
  • You do not have a history of organ transplant and you are not allergic to sulfur

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05152394Recruiting· Phase 1
Testing cord stem cell exosome treatment for Parkinson’s safety

This Phase 1 study tests whether a treatment made from donated umbilical cord “exosomes” is safe in people with Parkinson’s disease. It mainly looks at side effects and safety, and could help guide future treatments if it proves tolerable.

St John's
NCT05158101Recruiting· Phase 1
Nasal stem cell exosome treatment safety for stroke

This early-stage study (Phase 1) tests whether a tiny dose given through the nose is safe for people who have had a stroke. It uses exosomes made from adult umbilical cord stem cells, mainly to look for side effects and dosing safety.

St John's
NCT05152290Recruiting· Phase 1
Safety study of stem cell treatment for spinal cord injury

This Phase 1 study tests whether an off-the-shelf stem cell product made from donated umbilical cord tissue is safe for people with spinal cord injury. It mainly looks at side effects and safety, and may help pave the way for future effectiveness studies.

St John's
NCT05147701Recruiting· Phase 1
Testing stem cell treatment for NAION safety

This Phase 1 study tests whether lab-made stem cells taken from donated umbilical cord are safe for people with NAION. It mainly looks for side effects and safety rather than proving the treatment works.

St John's
NCT05018832Not yet recruiting· Phase 1
Tested stem cell infusion for traumatic brain injury safety

This early study tests whether an intravenous (through a vein) stem cell treatment made from donated umbilical cord tissue is safe for people with traumatic brain injury. It focuses mainly on side effects and safety, and only includes participants who meet several health and pregnancy-related safety checks.

St John's
NCT05018793Recruiting· Phase 1
Testing stem cell injections for spinal cord injury safety

This early study tests whether two types of stem cells—made from your own fat cells versus from donated umbilical-cord cells—are safe when injected into the fluid around the spinal cord. It may help researchers find safer cell-based options for people with spinal cord injury.

St John's

Hear when a new Peripheral Neuropathy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.